TRIAMTERENE

Post-LOE

triamterene capsules

ANDAORALCAPSULE

Approved

Aug 2019

Lifecycle

Post-LOE

Competitive Pressure

30/100

Data completeness

2/8 — Basic

Drug data last refreshed 22h ago

$0.0BPart D

Mechanism of Action

Pharmacologic Class:

Potassium-sparing Diuretic

Indications

Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.

External Resources

ClinicalTrials.gov

Active clinical trials for this drug

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.